By designating only one reference detailed drug as being the typical to which all generic versions have to be demonstrated for being bioequivalent, FDA hopes to stay away from possible sizeable variants among the generic drugs as well as their brand name counterpart. Quoted prices are for cash-paying out customers and are not valid with insuranc